D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$1.2B |
| 2 |
Boston Scientific
BSX
|
+$1.05B |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$934M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$924M |
| 5 |
JPMorgan Chase
JPM
|
+$922M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$3.2B |
| 2 |
NVIDIA
NVDA
|
+$1.58B |
| 3 |
Palantir
PLTR
|
+$901M |
| 4 |
Netflix
NFLX
|
+$883M |
| 5 |
iShares Core S&P 500 ETF
IVV
|
+$805M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.55% |
| 2 | Consumer Discretionary | 8.97% |
| 3 | Financials | 8.5% |
| 4 | Healthcare | 8.44% |
| 5 | Industrials | 7.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ABVX
2001
Abivax
ABVX
$11.9B
| $5.63M | ﹤0.01% |
50,550
+32,950
| +187% | +$3.9M |
|
2002
Keros Therapeutics
KROS
$211M
| $5.63M | ﹤0.01% |
509,608
-245,865
| -33% | -$3.8M |
|
2003
Arcus Biosciences
RCUS
$3.44B
| $5.6M | ﹤0.01% |
259,400
+173,830
| +203% | +$3.75M |
|
2004
AdvanSix
ASIX
$560M
| $5.6M | ﹤0.01% |
229,630
-36,917
| -14% | -$697K |
|
2005
OFG Bancorp
OFG
$2.12B
| $5.6M | ﹤0.01% |
138,335
+49,655
| +56% | +$2.01M |
|
2006
Weibo
WB
$1.9B
| $5.56M | ﹤0.01% |
635,256
-24,988
| -4% | -$251K |
|
|
FPI
2007
Farmland Partners
FPI
$424M
| $5.55M | ﹤0.01% |
494,364
+241,389
| +95% | +$2.77M |
|
2008
Tyler Technologies
TYL
$13.1B
| $5.55M | ﹤0.01% |
16,213
-32,383
| -67% | -$12.1M |
|
2009
PUT
Advance Auto Parts
AAP
$3.21B
| $5.54M | ﹤0.01% |
105,100
+55,000
| +110% | +$2.75M |
|
2010
Sonic Automotive
SAH
$3.17B
| $5.52M | ﹤0.01% |
+80,459
| New | +$5.02M |
|
2011
Samsara
IOT
$22.3B
| $5.52M | ﹤0.01% |
174,087
+163,730
| +1,581% | +$5M |
|
2012
CALL
Medtronic
MDT
$106B
| $5.51M | ﹤0.01% |
63,600
-77,600
| -55% | -$7.43M |
|
2013
Marcus Corp
MCS
$708M
| $5.51M | ﹤0.01% |
320,961
-22,349
| -7% | -$357K |
|
|
BCAX
2014
Bicara Therapeutics
BCAX
$1.82B
| $5.51M | ﹤0.01% |
276,943
+140,421
| +103% | +$2.42M |
|
2015
Royal Gold
RGLD
$16.1B
| $5.51M | ﹤0.01% |
21,644
-47,239
| -69% | -$12.5M |
|
2016
Badger Meter
BMI
$4.36B
| $5.5M | ﹤0.01% |
36,070
-1,719
| -5% | -$270K |
|
2017
CALL
Caesars Entertainment
CZR
$6.08B
| $5.49M | ﹤0.01% |
207,900
-134,000
| -39% | -$3.19M |
|
|
ALUB
2018
Alussa Energy Acquisition Corp II
ALUB
| $5.49M | ﹤0.01% |
+550,573
| New | +$5.51M |
|
2019
PUT
SM Energy
SM
$7.51B
| $5.49M | ﹤0.01% |
176,200
+79,200
| +82% | +$1.81M |
|
|
RAPP
2020
Rapport Therapeutics
RAPP
$2.04B
| $5.49M | ﹤0.01% |
175,449
-71,866
| -29% | -$2.02M |
|
|
INFQ
2021
Infleqtion Inc
INFQ
$1.98B
| $5.48M | ﹤0.01% |
+558,791
| New | +$6.36M |
|
2022
CALL
Duolingo
DUOL
$6.24B
| $5.48M | ﹤0.01% |
55,600
+1,000
| +2% | +$123K |
|
2023
Northern Oil and Gas
NOG
$2.31B
| $5.47M | ﹤0.01% |
187,205
-352,673
| -65% | -$9.13M |
|
2024
Organogenesis Holdings
ORGO
$337M
| $5.45M | ﹤0.01% |
2,297,974
+309,495
| +16% | +$1.07M |
|
2025
PUT
Zillow
Z
$7.76B
| $5.45M | ﹤0.01% |
131,600
-3,400
| -3% | -$181K |
|
Similar funds
D.E. Shaw & Co's Q1 2026 Portfolio in Review
As of Q1 2026, D.E. Shaw & Co held 5,226 positions worth $166B, down 8.8% from $182B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
D.E. Shaw & Co withdrew a net $15.1B in Q1 2026, closing 756 positions and reducing 1,922 holdings. Its most notable exit was iShares Core S&P 500 ETF, an estimated $805M position sold in full.
By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 19% a quarter earlier, followed by Consumer Discretionary and Financials.
Against the trend, D.E. Shaw & Co opened a new position in Venture Global Inc worth $211M.
- D.E. Shaw & Co's largest Q1 2026 buy was Venture Global Inc: 13,410,074 shares worth $211M.
- D.E. Shaw & Co added most to Broadcom in Q1 2026, an estimated $1.2B increase.
- D.E. Shaw & Co's biggest Q1 2026 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $3.2B.
- D.E. Shaw & Co fully exited iShares Core S&P 500 ETF in Q1 2026, selling an estimated $805M.
- D.E. Shaw & Co's ten largest holdings make up 11% of its $166B portfolio in Q1 2026.
- D.E. Shaw & Co opened 685 new positions and closed 756 in Q1 2026.
- D.E. Shaw & Co's portfolio value fell 8.8% quarter-over-quarter to $166B.
Based on D.E. Shaw & Co's 13F filing for Q1 2026, filed 15 May 2026.